Peptides Biosimilars Market Report

China Peptides Biosimilars Industry Market Research Report 2023-2029

  • POSTDATE：Sep 09, 2023
  • PAGES：227
  • REPORT CODE：GMM1785412
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Peptides Biosimilars industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Sandoz

    • Amgen

    • Samsung Biologics

    • Celltrion

    • Teva Pahrmaceutical

    • Biocon

    • Pfizer

    • Stada Arzneimittel AG

    • Mylan

    By Type:

    • Glucagon

    • Calcitonin

    By Application:

    • Growth Hormone Deficiency

    • Chronic Diseases

    • Oncology

    • Infectious Diseases

    • Other Diseases

    • Blood Disorders

    • Autoimmune Diseases

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Peptides Biosimilars Market Overview 2018-2029

    • 1.1 China Peptides Biosimilars Industry Development Overview

    • 1.2 China Peptides Biosimilars Industry Development History

    • 1.3 China Peptides Biosimilars Industry Market Size (2018-2029)

    • 1.4 China Peptides Biosimilars Market Analysis by Type from Production Side

      • 1.4.1 China Peptides Biosimilars Production Volume, Production Value and Growth Rate of Glucagon (2018-2029)

      • 1.4.2 China Peptides Biosimilars Production Volume, Production Value and Growth Rate of Calcitonin (2018-2029)

    • 1.5 China Peptides Biosimilars Market Analysis by Application from Consumption End

      • 1.5.1 China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiency (2018-2029)

      • 1.5.2 China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Chronic Diseases (2018-2029)

      • 1.5.3 China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.4 China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

      • 1.5.5 China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Other Diseases (2018-2029)

      • 1.5.6 China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)

      • 1.5.7 China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)

    • 1.6 China Peptides Biosimilars Market Analysis by Region

      • 1.6.1 North China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

    Chapter 2 China Peptides Biosimilars Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Peptides Biosimilars Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Peptides Biosimilars Market Status and Competition Analysis in 2023

      • 2.2.3 China Peptides Biosimilars Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Peptides Biosimilars Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Peptides Biosimilars Industry Development

    Chapter 3 Peptides BiosimilarsIndustry Chain Analysis

    • 3.1 Peptides Biosimilars Industry Chain

    • 3.2 Peptides Biosimilars Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Peptides Biosimilars Market

    • 3.3 Peptides Biosimilars Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Peptides Biosimilars Market

    Chapter 4 China Peptides Biosimilars Market, by Type

    • 4.1 China Peptides Biosimilars Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Peptides Biosimilars Total Production Volume and Growth Rate from Production Side

    • 4.5 China Peptides Biosimilars Production Volume and Growth Rate, by Type

      • 4.5.1 China Peptides Biosimilars Production Volume and Growth Rate of Glucagon

      • 4.5.2 China Peptides Biosimilars Production Volume and Growth Rate of Calcitonin

    Chapter 5 China Peptides Biosimilars Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Peptides Biosimilars Total Market Size and Growth Rate from Consumption End

    • 5.5 China Peptides Biosimilars Market Size and Growth Rate, by Application

      • 5.5.1 China Peptides Biosimilars Market Size and Growth Rate of Growth Hormone Deficiency

      • 5.5.2 China Peptides Biosimilars Market Size and Growth Rate of Chronic Diseases

      • 5.5.3 China Peptides Biosimilars Market Size and Growth Rate of Oncology

      • 5.5.4 China Peptides Biosimilars Market Size and Growth Rate of Infectious Diseases

      • 5.5.5 China Peptides Biosimilars Market Size and Growth Rate of Other Diseases

      • 5.5.6 China Peptides Biosimilars Market Size and Growth Rate of Blood Disorders

      • 5.5.7 China Peptides Biosimilars Market Size and Growth Rate of Autoimmune Diseases

    Chapter 6 China Peptides Biosimilars Market, by Region

    • 6.1 China Peptides Biosimilars Production Volume and Production Value, by Region

    • 6.2 China Peptides Biosimilars Sales Volume and Sales Value, by Region

    Chapter 7 North China Peptides Biosimilars Market Analysis

    • 7.1 North China Peptides Biosimilars Market, by Type

    • 7.2 North China Peptides Biosimilars Market, by Application

    Chapter 8 Central China Peptides Biosimilars Market Analysis

    • 8.1 Central China Peptides Biosimilars Market, by Type

    • 8.2 Central China Peptides Biosimilars Market, by Application

    Chapter 9 South China Peptides Biosimilars Market Analysis

    • 9.1 South China Peptides Biosimilars Market, by Type

    • 9.2 South China Peptides Biosimilars Market, by Application

    Chapter 10 East China Peptides Biosimilars Market Analysis

    • 10.1 East China Peptides Biosimilars Market, by Type

    • 10.2 East China Peptides Biosimilars Market, by Application

    Chapter 11 Northeast China Peptides Biosimilars Market Analysis

    • 11.1 Northeast China Peptides Biosimilars Market, by Type

    • 11.2 Northeast China Peptides Biosimilars Market, by Application

    Chapter 12 Southwest China Peptides Biosimilars Market Analysis

    • 12.1 Southwest China Peptides Biosimilars Market, by Type

    • 12.2 Southwest China Peptides Biosimilars Market, by Application

    Chapter 13 Northwest China Peptides Biosimilars Market Analysis

    • 13.1 Northwest China Peptides Biosimilars Market, by Type

    • 13.2 Northwest China Peptides Biosimilars Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Sandoz

        • 14.1.1 Sandoz Company Profile

        • 14.1.2 Sandoz Peptides Biosimilars Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Amgen

        • 14.2.1 Amgen Company Profile

        • 14.2.2 Amgen Peptides Biosimilars Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Samsung Biologics

        • 14.3.1 Samsung Biologics Company Profile

        • 14.3.2 Samsung Biologics Peptides Biosimilars Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Celltrion

        • 14.4.1 Celltrion Company Profile

        • 14.4.2 Celltrion Peptides Biosimilars Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Teva Pahrmaceutical

        • 14.5.1 Teva Pahrmaceutical Company Profile

        • 14.5.2 Teva Pahrmaceutical Peptides Biosimilars Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Biocon

        • 14.6.1 Biocon Company Profile

        • 14.6.2 Biocon Peptides Biosimilars Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer

        • 14.7.1 Pfizer Company Profile

        • 14.7.2 Pfizer Peptides Biosimilars Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Stada Arzneimittel AG

        • 14.8.1 Stada Arzneimittel AG Company Profile

        • 14.8.2 Stada Arzneimittel AG Peptides Biosimilars Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Mylan

        • 14.9.1 Mylan Company Profile

        • 14.9.2 Mylan Peptides Biosimilars Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Peptides Biosimilars Industry Research Conclusions

    • 15.2 Peptides Biosimilars Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Peptides Biosimilars Industry Market Size (2018-2029)

    • Figure China Peptides Biosimilars Production Volume, Production Value and Growth Rate of Glucagon (2018-2029)

    • Figure China Peptides Biosimilars Production Volume, Production Value and Growth Rate of Calcitonin (2018-2029)

    • Figure China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiency (2018-2029)

    • Figure China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Chronic Diseases (2018-2029)

    • Figure China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

    • Figure China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Other Diseases (2018-2029)

    • Figure China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)

    • Figure China Peptides Biosimilars Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)

    • Figure North China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Central China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure South China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure East China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Peptides Biosimilars Market Size and Growth Rate from 2018-2029

    • Figure Peptides Biosimilars Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Peptides Biosimilars Market Share by Type in 2018

    • Figure China Peptides Biosimilars Market Share by Type in 2023

    • Figure China Peptides Biosimilars Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Peptides Biosimilars Production Volume and Growth Rate of Glucagon (2018-2023)

    • Figure China Peptides Biosimilars Production Volume and Growth Rate of Calcitonin (2018-2023)

    • Figure China Peptides Biosimilars Market Share by Application in 2018

    • Figure China Peptides Biosimilars Market Share by Application in 2023

    • Figure China Peptides Biosimilars Total Market Size and Growth Rate from Consumption End

    • Figure China Peptides Biosimilars Market Size and Growth Rate of Growth Hormone Deficiency (2018-2023)

    • Figure China Peptides Biosimilars Market Size and Growth Rate of Chronic Diseases (2018-2023)

    • Figure China Peptides Biosimilars Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Peptides Biosimilars Market Size and Growth Rate of Infectious Diseases (2018-2023)

    • Figure China Peptides Biosimilars Market Size and Growth Rate of Other Diseases (2018-2023)

    • Figure China Peptides Biosimilars Market Size and Growth Rate of Blood Disorders (2018-2023)

    • Figure China Peptides Biosimilars Market Size and Growth Rate of Autoimmune Diseases (2018-2023)

    • Table China Peptides Biosimilars Production Volume by Region (2018-2023)

    • Table China Peptides Biosimilars Production Volume Share by Region (2018-2023)

    • Figure China Peptides Biosimilars Production Volume Share by Region (2018-2023)

    • Table China Peptides Biosimilars Production Value by Region (2018-2023)

    • Table China Peptides Biosimilars Production Value Share by Region (2018-2023)

    • Figure China Peptides Biosimilars Production Value Share by Region (2018-2023)

    • Table China Peptides Biosimilars Sales Volume by Region (2018-2023)

    • Table China Peptides Biosimilars Sales Volume Share by Region (2018-2023)

    • Figure China Peptides Biosimilars Sales Volume Share by Region (2018-2023)

    • Table China Peptides Biosimilars Sales Value by Region (2018-2023)

    • Table China Peptides Biosimilars Sales Value Share by Region (2018-2023)

    • Figure China Peptides Biosimilars Sales Value Share by Region (2018-2023)

    • Table North China Peptides Biosimilars Production Volume by Type (2018-2023)

    • Table North China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Figure North China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Table North China Peptides Biosimilars Sales Volume by Application (2018-2023)

    • Table North China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure North China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Central China Peptides Biosimilars Production Volume by Type (2018-2023)

    • Table Central China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Central China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Table Central China Peptides Biosimilars Sales Volume by Application (2018-2023)

    • Table Central China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Central China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Table South China Peptides Biosimilars Production Volume by Type (2018-2023)

    • Table South China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Figure South China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Table South China Peptides Biosimilars Sales Volume by Application (2018-2023)

    • Table South China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure South China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Table East China Peptides Biosimilars Production Volume by Type (2018-2023)

    • Table East China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Figure East China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Table East China Peptides Biosimilars Sales Volume by Application (2018-2023)

    • Table East China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure East China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Northeast China Peptides Biosimilars Production Volume by Type (2018-2023)

    • Table Northeast China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Northeast China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Table Northeast China Peptides Biosimilars Sales Volume by Application (2018-2023)

    • Table Northeast China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Southwest China Peptides Biosimilars Production Volume by Type (2018-2023)

    • Table Southwest China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Southwest China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Table Southwest China Peptides Biosimilars Sales Volume by Application (2018-2023)

    • Table Southwest China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Northwest China Peptides Biosimilars Production Volume by Type (2018-2023)

    • Table Northwest China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Figure Northwest China Peptides Biosimilars Production Volume Share by Type (2018-2023)

    • Table Northwest China Peptides Biosimilars Sales Volume by Application (2018-2023)

    • Table Northwest China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Peptides Biosimilars Sales Volume Share by Application (2018-2023)

    • Table Sandoz Company Profile

    • Table Sandoz Peptides Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Peptides Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Samsung Biologics Company Profile

    • Table Samsung Biologics Peptides Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Celltrion Company Profile

    • Table Celltrion Peptides Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Teva Pahrmaceutical Company Profile

    • Table Teva Pahrmaceutical Peptides Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Peptides Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Peptides Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Stada Arzneimittel AG Company Profile

    • Table Stada Arzneimittel AG Peptides Biosimilars Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Peptides Biosimilars Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US